FDA product code KTM: C3-Indirect Immunofluorescent Solid Phase
KTM is the FDA product code for c3-indirect immunofluorescent solid phase. It is a Class II device, regulated under 21 CFR 866.5240 and reviewed by the Immunology panel. Devices under KTM reach the market by 510(k); FDA lists no cleared 510(k)s for it.
Classification
| Field | Value |
|---|---|
| Device name | C3-Indirect Immunofluorescent Solid Phase |
| Device class | Class II |
| Regulation | 21 CFR 866.5240 |
| Review panel | IM — Immunology |
| Medical specialty | Immunology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
Recalls for KTM devices
FDA recall records list no recalls for product code KTM.
Frequently asked questions
What is FDA product code KTM?
KTM is the FDA product code for c3-indirect immunofluorescent solid phase. It is a Class II device, regulated under 21 CFR 866.5240 and reviewed by the Immunology panel.
What device class is KTM?
Class II, regulation 21 CFR 866.5240. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code KTM
- Run a recall and safety report across every KTM manufacturer
- Watch product code KTM for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times